(Q81482104)
Statements
The impact of the combination of baseline risk group and cytogenetic response on the survival of patients with chronic myeloid leukemia treated with interferon alpha (English)
Joerg Hasford
Markus Pfirrmann
Pat Shepherd
Joëlle Guilhot
Rüdiger Hehlmann
François-Xavier Mahon
Kazunori Ohnishi
Juan Luis Steegmann